Investment Rating - The report maintains a "Buy" rating for the pharmaceutical and biotechnology industry, specifically highlighting companies such as Yuyuan Pharmaceutical and CanSino Biologics for potential investment opportunities [1]. Core Insights - The mRNA vaccine sector is experiencing significant advancements, with mRNA technology leading the shift towards efficient and personalized immunotherapy. This technology offers three main competitive advantages: rapid production capabilities, enhanced safety profiles, and flexibility in antigen design, which supports tailored treatments for cancer patients [1][4]. - The report identifies promising sub-sectors within the industry, ranking them as follows: innovative drugs, research services, CXO, traditional Chinese medicine, medical devices, and pharmacies. It suggests a focus on high-growth areas such as innovative drugs, particularly in small nucleic acid therapies, and high-dividend sectors like traditional Chinese medicine and pharmacies [10][11]. Summary by Sections Market Performance - The A-share pharmaceutical index has shown a year-to-date increase of 6.66%, outperforming the CSI 300 index by 5.10%. The Hang Seng Biotechnology Index has also seen a year-to-date rise of 12.40% [4][9]. - Notable performers in the market include *ST Changyao (+70.37%) and Hualan Biological (+32.21%) for the week, while the worst performers include Kain Technology (-13.83%) and Aidi Pharmaceutical (-13.70%) [9]. Clinical Developments - Corcept Therapeutics has reported positive results from its Phase III trial for relacorilant, which shows survival benefits for patients with platinum-resistant ovarian cancer. Additionally, Maiwei Biologics has initiated its first patient dosing in the U.S. for its CDH17-ADC innovative drug targeting advanced colorectal and gastrointestinal tumors [4]. Investment Recommendations - Specific companies to watch include: - From the PD1 PLUS perspective: 3SBio, Kanyin Biologics, Innovent Biologics, and Zai Lab [11]. - From the ADC perspective: InnoCare Pharma, Kelun-Biotech, and Baillie Gifford [11]. - From the small nucleic acid perspective: Frontier Biotechnologies, Fuyuan Pharmaceutical, and Yuyuan Pharmaceutical [11]. - From the self-immune perspective: Kangnuo Pharmaceutical, Yifang Biologics, and Yipinhong [11]. - From the innovative drug leaders: BeiGene and HengRui Medicine [11]. - From the CXO and upstream research services: WuXi AppTec, Haoyuan Pharmaceutical, and Aopumai [11]. - From the medical device sector: United Imaging Healthcare and Yuyue Medical [11].

Macro Strategy - The report highlights the investment value of the GF CSI Media ETF (512980.SH), which is closely tracking the CSI Media Index (399971.SZ) and has a management fee of 0.5% per year and a custody fee of 0.1% per year. As of January 16, 2026, the ETF has a circulation scale of 10.759 billion yuan and an annualized return of 29.47% with a volatility ratio of 0.89, indicating reasonable risk control capabilities [1][12] - The underlying index focuses on AI applications, with a significant weight of 31.43% in GEO concept stocks, including key companies like BlueFocus, Yanshan Technology, and Kunlun Wanwei. The top ten weighted stocks account for 51.52% of the index, indicating a high concentration of component stocks [1][12] - The report emphasizes that the current media bull market is driven by AI technology transformation and the assetization of data factors, contrasting with the previous bull market driven by mobile internet traffic. The media sector's valuation is at a historical low, providing a high margin of safety for investors [1][12] Non-Bank Financial Industry - The report indicates that the non-bank financial sector is experiencing an upward trend in market conditions, with public fund holdings in the sector increasing to 2.42% by the end of 2025, up 0.82 percentage points from the previous quarter. However, the sector remains underweight compared to the market [5][16] - The report recommends key stocks such as China Life, Ping An, New China Life, China Pacific Insurance, and CITIC Securities, highlighting their potential to benefit from the improving market environment [5][16] - The average daily trading volume of equity funds reached 34.444 trillion yuan, a year-on-year increase of 155%, indicating a significant improvement in market activity [5][16] Real Estate Industry - The report notes that the real estate market is gradually stabilizing, with a narrowing decline in sales and construction metrics compared to 2024. The total development investment in 2025 was 8.3 trillion yuan, down 17.2% year-on-year, while the new construction area was 5.9 million square meters, down 20.4% [6][18][19] - Sales figures show a cumulative sales area of 8.8 million square meters, down 8.7% year-on-year, with a cumulative sales amount of 8.4 trillion yuan, down 12.6%. The decline in sales is narrowing, particularly in first-tier cities [6][18][19] - Investment recommendations include China Resources Land, China Merchants Shekou, and New City Holdings, with a focus on property management companies like China Resources Mixc Life and Greentown Service [6][18][19] Environmental Industry - The report discusses the growth potential of the waste incineration sector, particularly in Southeast Asia and India, where an estimated 500,000 tons per day of waste incineration capacity is expected, corresponding to an investment scale of approximately 250 billion yuan [7][20] - Companies like Weiming Environmental and Sanfeng Environment are highlighted for their overseas expansion and operational stability, with significant revenue increases driven by high electricity prices and processing fees in international markets [7][20] - The report emphasizes the importance of cost control in overseas projects, with potential for significant profit margins compared to domestic projects, particularly in Indonesia where new projects are expected to yield higher returns [7][20]

Market Performance - As of January 23, 2026, the North Exchange A-share index has 290 constituent stocks with an average market capitalization of 3.335 billion yuan[13] - The North Exchange 50 index rose by 2.60% this week, closing at 1588.66 points, while the Shanghai and Shenzhen 300 index fell by 0.62%[13] - The average daily trading volume for North Exchange A-shares reached 26.831 billion yuan, a decrease of 21.36% from the previous week[13] Economic Indicators - China's GDP for 2025 is projected at 140.19 trillion yuan, with a year-on-year growth of 5%[11] - The industrial production growth is primarily driven by high-tech industries, with notable increases in industrial robots (14.7%), new energy vehicles (8.7%), and integrated circuits (12.9%) in 2025[11] Investment Insights - The price-to-earnings (PE) ratios for North Exchange A-shares, ChiNext, Shanghai Main Board, Shenzhen Main Board, and Sci-Tech Innovation Board are 43.45, 43.34, 24.55, 25.51, and 44.65 respectively as of January 23, 2026[24] - The report suggests focusing on stocks with stable growth and valuation potential in the technology sector[24] Risks - Potential policy risks may affect investor sentiment and trading enthusiasm in the North Exchange[25] - Liquidity risks exist due to lower trading volumes compared to other boards, which may negatively impact the market[25] - There is a risk of companies not meeting profit expectations due to external market changes[25]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company plans to issue shares and cash to acquire 100% of Dehua Chip, which is a leading player in the domestic space photovoltaic power sector. This acquisition will enhance the company's capabilities in high-end compound semiconductor research and development [7] - The company has made significant advancements in photovoltaic technologies, including perovskite, heterojunction, and tandem solar cells, achieving notable efficiency breakthroughs [7] - The earnings forecast has been adjusted downward for 2025-2027 due to the high proportion of performance from wind farm transfers, with expected net profits of 770 million, 2.1 billion, and 3.17 billion yuan respectively for those years [7] Financial Projections - Total revenue is projected to be 27,158 million yuan in 2024, increasing to 43,200 million yuan by 2027, reflecting a compound annual growth rate (CAGR) of approximately 11.87% [1][8] - The net profit attributable to the parent company is expected to recover significantly, with a forecast of 346.11 million yuan in 2024, rising to 3,172.53 million yuan by 2027, indicating a substantial growth trajectory [1][8] - The earnings per share (EPS) is projected to increase from 0.15 yuan in 2024 to 1.40 yuan in 2027, demonstrating strong profitability growth [1][8] Market Data - The closing price of the company's stock is 21.65 yuan, with a market capitalization of approximately 48.96 billion yuan [5] - The company has a price-to-earnings (P/E) ratio of 141.46 for the current year, which is expected to decrease to 15.43 by 2027, indicating improving valuation as earnings grow [1][8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company plans to issue shares and cash to acquire 100% of Dehua Chip, which is a leading player in the domestic space photovoltaic power sector. This acquisition will enhance the company's capabilities in high-end compound semiconductor research and development [7] - The company has made significant advancements in photovoltaic technologies, including perovskite, heterojunction, and tandem solar cells, achieving notable efficiency breakthroughs [7] - The earnings forecast has been adjusted downwards for 2025-2027 due to the high proportion of performance from wind farm transfers, with expected net profits of 770 million, 2.1 billion, and 3.17 billion yuan respectively for those years [7] Financial Summary - Total revenue is projected to be 27.16 billion yuan in 2024, increasing to 43.2 billion yuan by 2027, with a compound annual growth rate of 11.87% [1][8] - The net profit attributable to the parent company is expected to recover significantly, with a forecast of 346 million yuan in 2024, rising to 3.17 billion yuan by 2027, reflecting a growth rate of 51.10% [1][8] - The latest diluted EPS is projected to increase from 0.15 yuan in 2024 to 1.40 yuan in 2027, indicating strong earnings growth potential [1][8]

Investment Rating - The report maintains a bullish outlook, focusing on long-term opportunities in cyclical industries [2][24]. Core Viewpoints - The macro timing model for January 2026 scored 0, indicating a 76.92% probability of an increase in the Wande All A Index over the following month, with an average expected gain of 3.18% [24][31]. - The report emphasizes the strong upward momentum in cyclical industries, particularly in non-ferrous metals and chemicals, driven by global macro events [24][25]. - Short-term investments in thematic sectors such as commercial aerospace, AI applications, and space photovoltaics have shown significant rebounds, although caution is advised due to potential volatility from rapid price increases [25][27]. Fund Size Statistics - In the period from January 19 to January 23, 2026, the top three increasing equity ETF types were: thematic index ETFs (59.135 billion), industry index ETFs (7.975 billion), and cross-border industry index ETFs (5.346 billion) [9][10]. - The top three increasing equity ETF products were: power grid equipment ETF (7.326 billion), chemical ETF (5.717 billion), and sci-tech chip ETF (3.953 billion) [10][14]. - The top three increasing equity ETF tracking indices were: segmented chemical index (9.829 billion), power grid equipment thematic index (7.326 billion), and SSH gold stock index (5.251 billion) [18][20]. Market Outlook - The report suggests a positive outlook for the A-share market in January 2026, with a focus on the micro-cap index and the CSI 500 leading the market [24][25]. - Long-term recommendations include a focus on non-ferrous metals and chemicals, with silver prices surpassing the psychological level of 100, indicating potential for further increases [24][25]. - The report anticipates a market characterized by oscillating upward trends, recommending a growth-oriented ETF allocation [67][68].

证券研究报告·固定收益·固收点评 固收点评 20260125 二级资本债周度数据跟踪 （20260119-20260123） [Table_Tag] [Table_Summary] 观点 ◼ 一级市场发行情况： 本周（20260119-20260123）银行间市场及交易所市场无新发行二级资本 债。 ◼ 二级市场成交情况： 本周（20260119-20260123）二级资本债周成交量合计约 3342 亿元，较 上周增加 691 亿元，成交量前三个券分别为 25 中行二级资本债 02BC （443.52 亿元）、25 广发银行二级资本债 01BC（219.80 亿元）和 25 中 行二级资本债 03A（BC）（77.53 亿元）。 分发行主体地域来看，成交量前三为广东省、山西省和山东省，分别约 为 2521 亿元、299 亿元和 147 亿元。 从到期收益率角度来看，截至 1 月 23 日，5Y 二级资本债中评级 AAA-、 AA+、AA 级到期收益率较上周涨跌幅分别为：-2.18BP、-2.84BP、- 3.84BP；7Y 二级资本债中评级 AAA-、AA+、AA 级到期收益率较上周 涨跌幅分别为：-2.72B ...

Investment Rating - The report maintains an "Overweight" rating for the photovoltaic equipment industry [1]. Core Insights - Elon Musk announced plans for 100GW photovoltaic capacity for both terrestrial and space applications, expected to be completed by the end of 2028 [4]. - The global satellite launch numbers are increasing exponentially, with silicon-based HJT technology being identified as the optimal solution for space photovoltaic applications due to its flexibility, lower costs, and independence from raw material constraints [4]. - The overseas terrestrial photovoltaic market is also experiencing strong demand, particularly in the U.S., where the compound annual growth rate for installed capacity is projected to exceed 20% from 2024 to 2029, with 2025 installations expected to surpass 60GW [4]. - Chinese photovoltaic equipment holds a dominant position globally, with over 80% of the world's capacity in silicon materials, wafers, cells, and modules expected in 2024 [4]. - Key companies recommended for investment include leading HJT equipment manufacturer "Maiwei," low-oxygen monocrystalline furnace leader "Jingsheng," zero-busbar welding machine leader "Aotewei," and slicing equipment leader "Gaomei" [4]. Summary by Sections Industry Trends - The report highlights the exponential growth in satellite launches and the increasing demand for space photovoltaic solutions, positioning silicon-based HJT as a short-term optimal alternative [4]. - The U.S. photovoltaic market is projected to see significant growth, with a forecasted compound annual growth rate exceeding 20% from 2024 to 2029 [4]. Company Recommendations - The report emphasizes investment in leading companies within the photovoltaic equipment sector, particularly those specializing in HJT technology and related equipment [4].

Fund Size Changes - The top three increasing equity ETF types from January 19 to January 23, 2026, are: Theme Index ETF (¥591.35 billion), Industry Index ETF (¥79.75 billion), and Cross-Border Industry Index ETF (¥53.46 billion) [9] - The top three decreasing equity ETF types during the same period are: Scale Index ETF (-¥3348.87 billion), Cross-Border Strategy Index ETF (-¥7.12 billion), and Style Index ETF (-¥0.19 billion) [9] Market Outlook - The macro timing model's score for January 2026 is 0, indicating a 76.92% probability of the Wande All A Index rising in the following month, with an average increase of 3.18% [24] - The report maintains a bullish outlook, emphasizing long-term opportunities in cyclical industries, particularly in non-ferrous metals and chemicals [24] - The price of London silver surpassed the psychological level of 100 on January 23, 2026, indicating potential for further increases [24] Investment Recommendations - The report suggests a focus on growth-oriented ETF allocations, particularly in sectors like commercial aerospace, AI applications, and space photovoltaics, which have shown short-term rebounds [27] - The recommended ETFs include those focused on chemical, electric grid equipment, and semiconductor sectors, with specific stocks highlighted for each ETF [69] Risk Considerations - The model's predictions are based on historical data, which may not hold in the future, and there are risks associated with macroeconomic performance falling short of expectations [70]

本周（20260119-20260123）绿色债券周成交额合计 635 亿元，较上周减 少 13 亿元。分债券种类来看，成交量前三为非金公司信用债、金融机 构债和利率债，分别为 300 亿元、241 亿元和 74 亿元；分发行期限来 看，3Y 以下绿色债券成交量最高，占比约 80.43%，市场热度持续；分 发行主体行业来看，成交量前三的行业为金融、公用事业、交运设备， 分别为 266 亿元、113 亿元和 34 亿元；分发行主体地域来看，成交量前 三为北京市、广东省、湖北省，分别为 187 亿元、81 亿元和 45 亿元。 ◼ 估值偏离度前三十位个券情况： 证券研究报告·固定收益·固收点评 固收点评 20260125 绿色债券周度数据跟踪 （20260119-20260123） [Table_Tag] [Table_Summary] 观点 ◼ 一级市场发行情况： 本周（20260119-20260123）银行间市场及交易所市场共新发行绿色债券 20 只，合计发行规模约 84.00 亿元，较上周减少 11.61 亿元。发行年限 多为 3 年、5 年；发行人性质为央企子公司、地方国有企业、大型民企、 中央金融企业 ...